HIV ribozyme gene therapy (Immusol)

N/A

Report date: 2022/02/09 09:59:02

Base Information

Drug NameHIV ribozyme gene therapy (Immusol)
Drug Alias NameHIVase 1
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionRNA inhibitors
TargetsRibonucleic Acid
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of California San DiegoImmusol
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesImmusolUniversity Of California San Diego
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A